<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31338107</article-id>
<article-id pub-id-type="pmc">6628876</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2019.00638</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Perspective</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetic Regulation at the Interplay Between Gut Microbiota and Host Metabolism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Miro-Blanch</surname>
<given-names>Joan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/445596" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yanes</surname>
<given-names>Oscar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/340164" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup><institution>Metabolomics Platform, IISPV, Department of Electronic Engineering, Universitat Rovira i Virgili</institution>, <addr-line>Tarragona</addr-line>, <country>Spain</country></aff>
<aff id="aff2">
<sup>2</sup><institution>Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM)</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Jane Mellor, University of Oxford, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Tomas J. Ekström, Karolinska Institute (KI), Sweden; Thomas Roeder, University of Kiel, Germany</p>
</fn>
<corresp id="fn001">*Correspondence: Oscar Yanes, <email xlink:href="mailto:oscar.yanes@urv.cat" xlink:type="simple">oscar.yanes@urv.cat</email>
</corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Epigenomics and Epigenetics, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>638</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Miro-Blanch and Yanes</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Miro-Blanch and Yanes</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Gut microbiota communities have coevolved for millions of years in a symbiotic relationship with their mammalian hosts. Elucidating and understanding the molecular mechanisms by which microbiota interacts with its host and how this contributes to the homeostasis of the host is crucial. One of these molecular relationships is the so-called chemical crosstalk between microbiota and host metabolisms, including the poorly explored epigenetic regulation of host tissues by the metabolic activity of gut microbiota in response to changes in diet. DNA methylation and histone modifications are epigenetic marks partly regulated by enzymes such as methylases and acetylases, whose activity depend on host and microbiota metabolites that act as substrates and cofactors for these reactions. However, providing a complete mechanistic description of the regulatory interactions between both metabolisms and the impact on the expression of host genes through an epigenetic modulation, remains elusive. This article presents our perspective on how metabolomic, metagenomic, transcriptomic, and epigenomic data can be used to investigate the “microbiota–nutrient metabolism–epigenetics axis.” We also discuss the implications and opportunities this knowledge may have for basic and applied science, such as the impact on the way we structure future research, understand, and prevent diseases like type 2 diabetes or obesity.</p>
</abstract>
<kwd-group>
<kwd>microbiota</kwd>
<kwd>epigenetics</kwd>
<kwd>metabolomics</kwd>
<kwd>metabolism</kwd>
<kwd>histones</kwd>
<kwd>omics</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Universitat Rovira i Virgili<named-content content-type="fundref-id">10.13039/501100007512</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="105"></ref-count>
<page-count count="9"></page-count>
<word-count count="3486"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Crosstalk Between Host and Gut Microbiota Metabolisms</title>
<p>The human body co-habit with a diverse community of symbiotic microorganisms and their set of genes, collectively known as the microbiome (<xref ref-type="bibr" rid="B92">Ursell et al., 2013</xref>). The acquisition of the initial microbiome is a dynamic rather than a static process during early life (<xref ref-type="bibr" rid="B26">Ferretti et al., 2018</xref>). A recent estimation of the number of bacterial cells over human cells in our body has reduced the ratio from 10:1 (<xref ref-type="bibr" rid="B77">Savage, 1977</xref>) to a 1.3:1 (<xref ref-type="bibr" rid="B79">Sender et al., 2016a</xref>; <xref ref-type="bibr" rid="B80">Sender et al., 2016b</xref>). This implies a similar number of bacterial and human cells in and on the human body. However, the human microbiome encodes for at least 100 times more genes than our genome (<xref ref-type="bibr" rid="B72">Qin et al., 2010</xref>). Therefore, the corresponding higher functionality of bacterial genes is a key aspect to understand existing metabolic interactions between the host and its microbiota.</p>
<p>The microbiota helps their hosts to digest dietary fiber; produces some important neurotransmitters (<xref ref-type="bibr" rid="B76">Sampson and Mazmanian, 2015</xref>; <xref ref-type="bibr" rid="B102">Yano et al., 2015</xref>; <xref ref-type="bibr" rid="B83">Strandwitz et al., 2018</xref>), hormones, and vitamins (<xref ref-type="bibr" rid="B39">Kau et al., 2011</xref>; <xref ref-type="bibr" rid="B87">Trial et al., 2016</xref>); helps in training the host immune system (<xref ref-type="bibr" rid="B39">Kau et al., 2011</xref>; <xref ref-type="bibr" rid="B21">Chu and Mazmanian, 2013</xref>); and protects against pathogens (<xref ref-type="bibr" rid="B97">Watanabe et al., 2017</xref>), among many other functions. However, unbalanced microbiota can also cause disease. Some common diseases in western societies such as obesity and type 2 diabetes are associated with shifts in the relative abundance of gut bacteria composition and functionality, compared to the ones observed in healthy individuals. The cause of the microbiota imbalance (dysbiosis) of unhealthy individuals across age and geography has been mainly correlated with dietary habits (<xref ref-type="bibr" rid="B88">Turnbaugh et al., 2008</xref>; <xref ref-type="bibr" rid="B24">De Filippo et al., 2010</xref>; <xref ref-type="bibr" rid="B64">Muegge et al., 2011</xref>; <xref ref-type="bibr" rid="B100">Wu et al., 2011</xref>; <xref ref-type="bibr" rid="B3">Arumugam et al., 2011</xref>; <xref ref-type="bibr" rid="B61">Menni et al., 2017</xref>). Therefore, the so-called chemical crosstalk between the microbiota and its host has tangible consequences for the physiological state of the host (<xref ref-type="bibr" rid="B81">Sharon et al., 2014</xref>; <xref ref-type="bibr" rid="B15">Caesar et al., 2015</xref>; <xref ref-type="bibr" rid="B93">Ussar et al., 2016</xref>). However, the molecular mechanisms by which microbiota chemically interacts with host cells and regulate gene expression remain largely unknown. In this regard, the role that certain host-microbiota derivate metabolites may exert on epigenetic events at the DNA, RNA, and histone level needs to be further investigated.</p>
</sec>
<sec id="s2">
<title>The “Microbiota–Nutrient Metabolism–Host Epigenetic” Axis</title>
<p>Differences in the microbiota or epigenome in two genetically identical organisms, such as same-sex inbred mice or monozygous twins, can create differences in susceptibilities to diseases including obesity and type 2 diabetes (<xref ref-type="bibr" rid="B53">Ling and Groop, 2009</xref>; <xref ref-type="bibr" rid="B27">Franks and Ling, 2010</xref>). As with gut microbiota, new studies have demonstrated that epigenetic events are highly dynamic, changing in response to nutrient availability (<xref ref-type="bibr" rid="B10">Bouchard et al., 2010</xref>; <xref ref-type="bibr" rid="B36">Hullar and Fu, 2014</xref>) or physical exercise (<xref ref-type="bibr" rid="B49">Laker et al., 2017</xref>). DNA methyltransferases, DNA hydroxylases, histone acetyltransferases, histone deacetylases, histone methyltransferases, and histone demethylases are enzymes responsible for adding or removing these dynamic epigenetic modifications. In this regard, endogenous metabolites can regulate gene expression through epigenetic events in host cells (<xref ref-type="bibr" rid="B38">Katada et al., 2012</xref>). For instance, histone deacetylation regulated by sirtuin family deacetylases is regulated by the NAD<sup>+</sup>/NADH ratio, acetyl-CoA, O-acetyl-ADP-ribose, and nicotinamide (<xref ref-type="bibr" rid="B69">Peleg et al., 2016</xref>; <xref ref-type="bibr" rid="B74">Ringel et al., 2018</xref>). Whether gut microbiota metabolism is regulating the concentration and/or activity of endogenously produced metabolites by the host remains largely unexplored, and it is only recently that an increasing number of researchers have started to investigate this possibility (<xref ref-type="bibr" rid="B46">Krautkramer et al., 2016</xref>; <xref ref-type="bibr" rid="B1">Aleksandrova et al., 2017</xref>; <xref ref-type="bibr" rid="B75">Romano et al., 2017</xref>). <xref ref-type="bibr" rid="B46">Krautkramer and colleagues (2016)</xref> have demonstrated that microbial colonization regulates global histone acetylation and methylation in multiple host tissues in a diet-dependent manner.</p>
<p>Short-chain fatty acids (SCFAs) are exclusively produced by the microbial fermentation of dietary carbohydrates, and their abundances are regulated by the composition of the microbiota (<xref ref-type="bibr" rid="B19">Chen et al., 2007</xref>; <xref ref-type="bibr" rid="B16">Cai et al., 2011</xref>). Importantly, SCFAs, particularly butyrate and acetate, produced by the microbiota, inhibit histone deacetylases (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>) (<xref ref-type="bibr" rid="B60">Maslowski and MacKay, 2011</xref>). Increased levels of histone acetylation promote decondensation and relaxation of chromatin, supporting a more transcriptionally active state of chromatin (<xref ref-type="bibr" rid="B7">Bolduc et al., 2017</xref>).</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>The “microbiota–nutrient metabolism–epigenetics” axis. Most of the key molecules involved in one-carbon metabolism are dietary- and microbiota-dependent, being susceptible to gut dysbiosis or diet intervention. Folate is the precursor of dihydrofolate (DHF) and tetrahydrofolate (THF), and dietary intake is the only source for humans. Together with vitamin B12, 5’methy-THF is in charge of remethylating homocysteine (Hcy) to methionine (Met), a crucial step in the process of transferring a methyl group to DNA or histones through SAM. The ratio of S-adenosyl homocysteine (SAH) to SAM regulates the overall methylation status of the genome at the DNA or histone level. Vitamins B12, B2, and B6 are key cofactors in the folate cycle that are produced by the microbiota or ingested through diet. Intermediates of the tricarboxylic acid cycle (TCA) are known to positively or negatively regulate histone methylation. For example, alpha-ketoglutarate (α-KG) is known to be an essential substrate for jumonji C histone demethylases (jmjC), and levels of succinate and fumarate can inhibit jmjC demethylases. α-Ketoglutarate is a co-substrate of TET dioxygenases in charge of demethylation processes of histones and DNA. As for jmjC demethylases, increased levels of fumarate and succinate can inhibit TET enzymes with the consequent increased levels of histone and DNA methylation. Short-chain fatty acids (SCFAs) produced by the gut microbiota are also known to inhibit or promote histone PTMs. Butyrate and propionate are inhibitors of sirtuins deacetylases enzymes. Acetate from gut fermentation contributes to the pool of intermediate molecules known to form acetyl-coenzyme A, the major acetyl group donor for histone acetyl transferases (HATs). Acetate is also known to be an inhibitor of histone deacetylases (HDAC), increasing histone acetylation levels and regulating chromatin accessibility. Whether levels of FAD/FADH<sub>2</sub>, NAD/NADH, TCA intermediates, and other host endogenous epigenetically relevant metabolites are modulated by gut microbiota metabolism needs to be further investigated. DMG, dimethylglycine; ATP, adenosine triphosphate; ADP, adenosine diphosphate; FAD/FADH<sub>2</sub>, Flavin adenine dinucleotide; NAD<sup>+</sup>/NADH, nicotinamide adenine dinucleotide.</p>
</caption>
<graphic xlink:href="fgene-10-00638-g001"></graphic>
</fig>
<p>Alteration of chromatin state is a possible mechanism by which gut microbiota induces host immune maturation (<xref ref-type="bibr" rid="B17">Cani et al., 2012</xref>; <xref ref-type="bibr" rid="B78">Seeley et al., 2018</xref>). Recognition of a “self” antigen should not only be limited to mammalian host antigens, but also symbiotic microbiota antigens forming part of the whole human ecosystem in a healthy state. The human leukocyte antigen (HLA) or major histocompatibility complex (MHC) gene system encodes many antigen-presenting proteins, which are essential to recognize and distinguish “self” from “non-self” antigens. Colonization of germ-free mice has demonstrated the capacity of microbiota-specific species to activate MHC class II genes (<xref ref-type="bibr" rid="B91">Umesaki et al., 1995</xref>). However, little is known about the immunomodulatory effect of microbial metabolites. A poorly explored possibility is that epigenetically relevant metabolites such as SCFA, highly influenced by microbiota composition, would regulate MHC gene expression by coordinating activity of enzymes that acetylate and methylate histones and DNA allowing chromatin accessibility (<xref ref-type="bibr" rid="B86">Ting and Trowsdale, 2002</xref>).</p>
<p>Regulation of DNA and histone methylation may be driven by complex microbiota–host metabolism interactions involving S-adenosyl methionine (SAM), derived from the essential amino acid methionine through diet (<xref ref-type="bibr" rid="B71">Poirier et al., 2001</xref>). Folate plays an essential role by re-methylating homocysteine to methionine (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>), thereby ensuring the provision of SAM (<xref ref-type="bibr" rid="B40">Kim, 2005</xref>; <xref ref-type="bibr" rid="B47">Krautkramer et al., 2017</xref>). In this regard, enzymes that are depleted in obese microbiomes are frequently involved in cofactor and vitamin metabolism (<xref ref-type="bibr" rid="B31">Greenblum et al., 2012</xref>), including the production of cobalamin (vitamin B12), pyridoxal phosphate (the active form of vitamin B6), tetrahydrofolate, and folate (<xref ref-type="bibr" rid="B3">Arumugam et al., 2011</xref>; <xref ref-type="bibr" rid="B39">Kau et al., 2011</xref>; <xref ref-type="bibr" rid="B103">Yatsunenko et al., 2012</xref>). Taken together, dysbiosis of microbiota can influence SAM levels and, as a result, alter the methylation status of DNA and histones. Whether dysbiosis of microbiota can alter α-ketoglutarate and succinate levels in specific peripheral host tissues, and regulate the rate of DNA demethylation, is a plausible but little explored possibility. Ten-eleven translocation (TET) enzymes are a key family of DNA and histone demethylases that use α-ketoglutarate as co-substrate. However, due to the structural similarity with α-ketoglutarate, Tets are susceptible to competitive inhibition by fumarate and succinate, causing an increase in histone and DNA methylation levels (<xref ref-type="bibr" rid="B2">An et al., 2017</xref>).</p>
<p>Another modification that could be regulated by microbial metabolism is histone phosphorylation. In response to a low ATP/AMP ratio indicative of energy status, the AMP-activated protein kinase (AMPK) can translocate to chromatin and phosphorylate histone H2B (<xref ref-type="bibr" rid="B14">Bungard et al., 2010</xref>). Changes in AMPK activity have been reported in obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease (<xref ref-type="bibr" rid="B43">Kola et al., 2008</xref>). Interestingly, germ-free mice were resistant to obesity and insulin resistance that develop after consuming a Western-style, high-fat, and sugar-rich diet (<xref ref-type="bibr" rid="B4">Bäckhed et al., 2007</xref>). The persistently lean phenotype of germ-free animals was associated with increased skeletal muscle and liver levels of phosphorylated AMPK. It is also tempting to speculate that phosphotransferase systems (PTS) overrepresented in the Western diet microbiomes (<xref ref-type="bibr" rid="B88">Turnbaugh et al., 2008</xref>; <xref ref-type="bibr" rid="B89">Turnbaugh et al., 2009</xref>) could have an impact on this histone modification.</p>
<p>In short, dysbiosis and reduction of the microbiota diversity can potentially alter the levels of nutrients and metabolites that can potentially act as regulators of DNA methylation and histone modifications either by directly inhibiting enzymes that catalyze the processes, or by altering the availability of substrates necessary for the enzymatic reactions.</p>
</sec>
<sec id="s3">
<title>Holobionts, Multifactorial Diseases, and Omic Technologies</title>
<p>Hosts and their microbiota have a very intimate relationship and should be considered as a single biological and evolutionary unit, termed holobiont (<xref ref-type="bibr" rid="B104">Youle et al., 2013</xref>; <xref ref-type="bibr" rid="B18">Carrier and Reitzel, 2017</xref>; <xref ref-type="bibr" rid="B32">Groussin et al., 2017</xref>; <xref ref-type="bibr" rid="B94">van de Guchte et al., 2018</xref>). In this regard, we could arguably talk about holo–genome, –transcriptome, –proteome, or –metabolome, referring to the combination of both, host and host microbiota molecular layers or modules of information at the DNA, RNA, protein, or metabolite level, respectively (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>). To investigate the dynamics of the holobiont ecosystem network, multi-omic approaches bring unprecedented advantages. Diseases such as obesity and diabetes are known to be multifactorial, and the collection of several -<italic>omic</italic> data (<xref ref-type="table" rid="T1">
<bold>Table 1</bold>
</xref>) from the same holobiont specimen, may provide a detailed molecular description and new mechanistic insights of how dietary nutrients and gut microbiota metabolism can regulate the host phenotype through gene expression and epigenetic and metabolic regulation.</p>
<fig id="f2" position="float">
<label>Figure 2</label>
<caption>
<p>The human holobiont. Representation of few examples of known interactions between different molecular levels within a holobiont. Exercise, environment, and diet can affect the physiology and molecular interactions between human (host) and its microbiota at the DNA, RNA, protein, or metabolite level. As an example, fecal host micro RNAs (miRNAs) are used by the host to modulate the composition of its own gut microbiota, interacting at the microbiota RNA and DNA levels to control microbial growth (<xref ref-type="bibr" rid="B55">Liu et al., 2016</xref>). Short-chain fatty acids (SCFAs), products of gut bacterial anaerobic fermentation of dietary fiber, have been proved to cause changes in histone PTMs in multiple host tissues (<xref ref-type="bibr" rid="B46">Krautkramer et al., 2016</xref>). Butyrate is a potent histone deacetylase inhibitor (HDACi), regulating the transcription levels of genes involved in colorectal tumorigenesis (<xref ref-type="bibr" rid="B34">Hassig et al., 1997</xref>). The direct transformation of dietary nutrients (<xref ref-type="bibr" rid="B81">Sharon et al., 2014</xref>) and secondary products of host metabolites such as primary bile acids (<xref ref-type="bibr" rid="B96">Wahlström et al., 2016</xref>) evidencies the strong interdependency between host and microbiota. Folate production by <italic>Biffidobacterium</italic> spp. is another example of how gut microbiota products can affect epigenetics such as DNA or histone methylation (<xref ref-type="bibr" rid="B68">Paul et al., 2015</xref>). Microbiota diversity shifts, products, or bacterial structural components such as flagellin can cause the activation of the immune system as well as impact the immune reconstitution after certain diseases or immunotherapy (<xref ref-type="bibr" rid="B59">Manzo and Bhatt, 2015</xref>). Immune system maturation and allergic disease development are other examples of how the host and its microbiome interact (<xref ref-type="bibr" rid="B20">Christmann et al., 2015</xref>).</p>
</caption>
<graphic xlink:href="fgene-10-00638-g002"></graphic>
</fig>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Popular omic techniques in the fields of epigenomics, metagenomics, metabolomics, and proteomics.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1" valign="top">Omics</th>
<th colspan="1" rowspan="1" valign="top">Focus</th>
<th colspan="1" rowspan="1" valign="top">Trait studied</th>
<th colspan="1" rowspan="1" valign="top">Techniques used</th>
<th colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="14" valign="top">Epigenomics</td>
<td colspan="1" rowspan="5" valign="top">DNA modifications</td>
<td colspan="1" rowspan="3" valign="top">5-methylcytosine</td>
<td colspan="1" rowspan="1" valign="top">WGBS (whole genome bisulfite Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B54">Lister et al., 2009</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">RRBS (reduced represented bisulfite Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B101">Xi et al., 2012</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">MeDIP-Seq (methylated DNA IP Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B25">Down et al., 2008</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">5-hydroxymethylation</td>
<td colspan="1" rowspan="1" valign="top">oxBS-Seq (oxidative bisulfite Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B8">Booth et al., 2012</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">5-formylcytosine</td>
<td colspan="1" rowspan="1" valign="top">RedBS-Seq (reduced bisulfite Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B9">Booth et al., 2014</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">RNA modifications</td>
<td colspan="1" rowspan="1" valign="top">6-methyladenosine</td>
<td colspan="1" rowspan="1" valign="top">m6A-Seq (m6A specific methylated IP Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B62">Meyer et al., 2012</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="4" valign="top">DNA 3D structure</td>
<td colspan="1" rowspan="4" valign="top">DNA structure and protein interaction</td>
<td colspan="1" rowspan="1" valign="top">ChIP-Seq (chromatin IP Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B5">Barski et al., 2007</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">ATAC-Seq (assay transposase accessible chromatin Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B13">Buenrostro et al., 2013</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">Hi-C (chromatin conformation capture)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B52">Lieberman-Aiden et al., 2009</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">DNase-Seq (DNase I hypersensitive sites Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B11">Boyle et al., 2008</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="4" valign="top">RNA transcripts</td>
<td colspan="1" rowspan="4" valign="top">Transcribed DNA</td>
<td colspan="1" rowspan="1" valign="top">RNA-Seq (mRNA/size/strand Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B63">Mortazavi et al., 2008</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GRO-Seq (global run-on-sequencing Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B23">Core et al., 2008</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">NET-Seq (native elongating transcript Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B22">Churchman and Weissman, 2011</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">UMI method (unique molecular identifiers)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B41">Kivioja et al., 2012</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="3" valign="top">Metagenomics</td>
<td colspan="1" rowspan="1" valign="top">Marker gene</td>
<td colspan="1" rowspan="1" valign="top">Hypervariable region</td>
<td colspan="1" rowspan="1" valign="top">16S gene (16S amplicon PCR/sequencing)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B99">Woese and Fox, 1977</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">Whole metagenome</td>
<td colspan="1" rowspan="1" valign="top">Whole genome</td>
<td colspan="1" rowspan="1" valign="top">DNA-Seq (regular DNA Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B90">Tyson et al., 2004</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">Metatranscriptome</td>
<td colspan="1" rowspan="1" valign="top">RNA</td>
<td colspan="1" rowspan="1" valign="top">RNA-Seq (regular RNA Seq)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B29">Gilbert et al., 2008</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="4" valign="top">Metabolomics</td>
<td colspan="1" rowspan="1" valign="top">Targeted</td>
<td colspan="1" rowspan="1" valign="top">Known metabolites</td>
<td colspan="1" rowspan="1" valign="top">QqQ (triple quadrupole)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B56">Lu et al., 2008</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="3" valign="top">Untargeted profiling</td>
<td colspan="1" rowspan="3" valign="top">Unknown metabolites</td>
<td colspan="1" rowspan="1" valign="top">qTOF-MS (quadrupole time of flight)</td>
<td colspan="1" rowspan="2" valign="top">(<xref ref-type="bibr" rid="B67">Patti et al., 2012</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">Orbitrap-MS</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">NMR (nuclear magnetic resonance)</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B12">Brindle et al., 2002</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="4" valign="top">Proteomics</td>
<td colspan="1" rowspan="4" valign="top">Histones PTMs</td>
<td colspan="1" rowspan="4" valign="top">H2A, H2B, H3, and H4 modifications</td>
<td colspan="1" rowspan="1" valign="top">Bottom-up</td>
<td colspan="1" rowspan="3" valign="top">(<xref ref-type="bibr" rid="B82">Sidoli et al., 2012</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">Middle-down</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">Top-down</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">MALDI-imaging mass spectrometry</td>
<td colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B48">Lahiri et al., 2016</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>The integration and combination of these techniques have the potential to reveal more mechanistic insights on how gut microbiota influence epigenetics and gene expression, ultimately affecting host health. IP, immune precipitation; Seq, sequencing; m6A, 6’methyl adenosine; MS, mass spectrometry; LC, liquid chromatography; GC, gas chromatography; PTMs, posttranslational modifications; MALDI, Matrix-assisted laser desorption ionization.</p>
</table-wrap-foot>
</table-wrap>
<p>To study a complex metabolic disorder such as familial type 1 diabetes mellitus (T1D), <xref ref-type="bibr" rid="B35">Heintz-Buschart et al. (2016)</xref> used a combination of host genomics and proteomics together with metagenomics, metatranscriptomics, and metaproteomics to demonstrate a pronounced family membership effect in the structuration and functionality of the microbiomes. They observed a correlation between certain human pancreatic enzymes and the expression of specific microbial genes involved in key T1D metabolic transformations. <xref ref-type="bibr" rid="B46">Krautkramer et al. (2016)</xref> used a combination of metabolomic, proteomics of histones, transcriptomic, and metagenomic techniques in conventional and germ-free mice, to demonstrate how SCFAs produced by the microbiota, or supplemented exogenously to germ-free mice, regulate histone post-translational modifications (PTMs). Comparing histone PTMs and transcriptional profiles between conventional, germ-free mice and germ-free mice supplemented with SCFAs, Krautkramer et al. concluded that SCFAs alone are partially causative for histone PTMs. In the same direction, <xref ref-type="bibr" rid="B84">Thaiss et al. (2016)</xref> used a combination of metagenomics, transcriptomics, epigenomics, and metabolomics together with imaging electron microscopy, to identify a diurnal rhythmicity in the microbial biogeography, metabolic profile, and metagenomic functionality as critical orchestrators of host epigenetic marks and gene expression. Thaiss et al. have demonstrated that host epigenetic and transcriptional circadian oscillations are partially dependent on environmental signals such as microbiome metabolite dynamics in the intestines and that peripheral organs “sense and adapt” to this circadian metabolite rhythms in a similar manner.</p>
<p>Overall, multi-omic approaches will facilitate the structuration of future research, improve patient stratification toward a more personalized care, and open new avenues to evaluate the effectiveness of functional probiotics, functional foods, or nutritional interventions aimed at regulating host gene expression in health and disease.</p>
</sec>
<sec id="s4">
<title>Opportunities for Biomedical and Clinical Research</title>
<p>The development and improvement of new technologies and bioinformatic tools are advancing biomedical research at a fast pace. Multi-<italic>omic</italic> experiments are allowing researchers to obtain mechanistic insights on the human holobiont homeostasis, improving decision-making for next experiments to be performed. In a research context, extensive collection of -<italic>omic</italic> data will allow integration of information into modulable and controlled models of microbial communities (<xref ref-type="bibr" rid="B28">Franzosa et al., 2015</xref>). However, it is important to identify confounding factors in longitudinal -<italic>omic</italic> studies. Standardization of methods and techniques to reduce noise and bias in microbiome research will improve how we translate lab findings into the clinic (<xref ref-type="bibr" rid="B42">Knight et al., 2018</xref>).</p>
<p>Using <italic>germ-free</italic> or gnotobiotic mouse models provide a framework to manipulate the gut microbial composition in a controlled manner. These models can be used to study the chemical crosstalk between host and microbiota by uncovering specific epigenetic changes in host cells induced by colonization of specific bacterial strains. Colonizing gnotobiotic mice with single strains or small bacterial consortia, instead of whole fecal transplants, might bring more accurate information to understand specific molecular mechanisms and molecular pathways involved in the host epigenetic regulations. Microbiota-induced dysbiosis with antibiotics might provide a useful approach to validate findings in gnotobiotic models by partially mimicking the effects of absence of microbiota or a reduction in the microbial diversity. Interestingly, organoids might also provide a challenging but very useful <italic>in vitro</italic> culturing system to study host–microbiota interactions (<xref ref-type="bibr" rid="B98">Williamson et al., 2018</xref>).</p>
<p>In a clinical context, gaining knowledge on the “microbiota–nutrient metabolism–host epigenetics axis” using multiple -<italic>omic</italic> approaches in combination with microbiota modulation therapies, has the potential to prevent and treat more efficiently metabolic diseases:</p>
<list list-type="order">
<list-item>
<p>Fecal microbiota transplantation (FMT): The use of microbiota modulation therapies such as FMT to treat recurrent <italic>Clostridium difficile</italic> infections has been proved significantly more efficient than a vancomycin treatment (<xref ref-type="bibr" rid="B70">Petrof and Khoruts, 2012</xref>; <xref ref-type="bibr" rid="B95">van Nood et al., 2013</xref>). Recently, the potential of FMT as microbiome modulation technique for treating metabolic (<xref ref-type="bibr" rid="B44">Kootte et al., 2017</xref>) (<xref ref-type="bibr" rid="B33">Gupta et al., 2016</xref>), neurological (<xref ref-type="bibr" rid="B37">Kang et al., 2017</xref>), and immunological disorders (<xref ref-type="bibr" rid="B66">Pamer, 2014</xref>) has been tested, improving these conditions by partially restoring microbiota diversity and functionality. Assessing long-term host epigenetic effects of FMT has to be further investigated.</p>
</list-item>
<list-item>
<p>Microbiota as drug target: The unique microbiome composition of each person is probably responsible for different susceptibilities to the same nutrient, pollutant, or drug treatment (<xref ref-type="bibr" rid="B45">Koppel et al., 2017</xref>). Microbiota-derived metabolites can enter the bloodstream and interact with drug treatments, impacting the efficacy, toxicity, and clearance of the drug. Diagnosing or treating diseases using microbiota-targeted drugs, probiotics, and use of bacteriophages or engineered bacteria has recently re-emerged (<xref ref-type="bibr" rid="B6">Bhat and Kapila, 2017</xref>; <xref ref-type="bibr" rid="B50">Landry and Tabor, 2017</xref>; <xref ref-type="bibr" rid="B58">Manrique et al., 2017</xref>; <xref ref-type="bibr" rid="B57">Maier et al., 2018</xref>).</p>
</list-item>
<list-item>
<p>Nutritional intervention, probiotics, and prebiotics: The acute consumption of a cocktail of probiotics containing a selection of five strains of <italic>Lactobacillus</italic> and five strains of <italic>Enterococcus</italic> modulates the microbiome and enhances SCFAs production in human and mice (<xref ref-type="bibr" rid="B65">Nagpal et al., 2018</xref>). The consumption of some probiotics has proven to be beneficial and ameliorates stress felt in healthy women (<xref ref-type="bibr" rid="B85">Tillisch Kirsten, 2013</xref>), improves insulin sensitivity (<xref ref-type="bibr" rid="B30">Gomes et al., 2014</xref>), protects against infections (<xref ref-type="bibr" rid="B73">Reid and Burton, 2002</xref>), and helps to restore microbiota after distortion by antibiotics (<xref ref-type="bibr" rid="B51">Langdon et al., 2016</xref>), among other benefits. Promoting SCFAs producing bacteria in the host gut by a nutritional intervention that increases fiber consumption (<xref ref-type="bibr" rid="B105">Zhao et al., 2018</xref>) may have an epigenetic effect in the host (<xref ref-type="bibr" rid="B46">Krautkramer et al., 2016</xref>).</p>
</list-item>
</list>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions and Perspective</title>
<p>The study of the “microbiota–nutrient metabolism–host epigenetic” axis has great potential to reveal the molecular mechanisms by which gut microbiota composition affects the expression of genes in their hosts. In a human holobiont context, this axis is relevant to understand, prevent, diagnose, and treat the existing epidemic of metabolic disorders such as type 2 diabetes and obesity. Microbiota is a key player in health outcomes due to the potential myriad of metabolites that can produce and interact with any cell of our body through systemic circulation. Those metabolites are coming from direct transformations of nutrients available in the gut microbiota or from secondary transformed host products. The link between epigenetic marks and gut microbes appears to be mediated by host-microbial metabolites that act as substrates and cofactors for key epigenetic enzymes in the host. A disruption in the composition of the gut microbiota may lead to unbalanced key metabolites that sequentially may impact epigenetic pathways and alter gene expression. The implementation of multi-omic approaches to study the human holobiont will facilitate the stratification of patients toward a personalized-oriented care, improving disease prevention, diagnostics, drug election, and treatment efficiency.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data Availability</title>
<p>All datasets analyzed for this study are cited in the manuscript and/or the supplementary files.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>JM and OY designed, wrote, revised, and approved the submitted version of the manuscript.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 675610. OY thanks the following bodies for funding: Ministerio de Economia y Competitividad (MINECO) (BFU2017-87958-P) and the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), an initiative of Instituto de Investigacion Carlos III (ISCIII).</p>
</sec>
<sec id="s9">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aleksandrova</surname><given-names>K.</given-names></name><name><surname>Romero-Mosquera</surname><given-names>B.</given-names></name><name><surname>Hernandez</surname><given-names>V.</given-names></name></person-group> (<year>2017</year>). <article-title>Diet, gut microbiome and epigenetics: emerging links with inflammatory bowel diseases and prospects for management and prevention</article-title>. <source/>Nutrients
<volume>9</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.3390/nu9090962</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>An</surname><given-names>J.</given-names></name><name><surname>Rao</surname><given-names>A.</given-names></name><name><surname>Ko</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>TET family dioxygenases and DNA demethylation in stem cells and cancers</article-title>. <source/>Exp. Mol. Med.
<volume>49</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/emm.2017.5</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arumugam</surname><given-names>M.</given-names></name><name><surname>Raes</surname><given-names>J.</given-names></name><name><surname>Pelletier</surname><given-names>E.</given-names></name><name><surname>Le Paslier</surname><given-names>D.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Mende</surname><given-names>D. R.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Enterotypes of the human gut microbiome</article-title>. <source/>Nature
<volume>473</volume>, <fpage>174</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1038/nature09944</pub-id>
<pub-id pub-id-type="pmid">21508958</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bäckhed</surname><given-names>F.</given-names></name><name><surname>Manchester</surname><given-names>J. K.</given-names></name><name><surname>Semenkovich</surname><given-names>C. F.</given-names></name><name><surname>Gordon</surname><given-names>J. I.</given-names></name></person-group> (<year>2007</year>). <article-title>Mechanisms underlying the resistance to diet-induced obesity in germ-free mice</article-title>. <source/>Proc. Natl. Acad. Sci.
<volume>104</volume>, <fpage>979</fpage>–<lpage>984</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0605374104</pub-id>
<pub-id pub-id-type="pmid">17210919</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barski</surname><given-names>A.</given-names></name><name><surname>Wei</surname><given-names>G.</given-names></name><name><surname>Chepelev</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Cui</surname><given-names>K.</given-names></name><name><surname>Zhao</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>High-resolution profiling of histone methylations in the human genome</article-title>. <source/>Cell
<volume>129</volume>, <fpage>823</fpage>–<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.05.009</pub-id>
<pub-id pub-id-type="pmid">17512414</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bhat</surname><given-names>M. I.</given-names></name><name><surname>Kapila</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals</article-title>. <source/>Nutr. Rev.
<volume>75</volume>, <fpage>374</fpage>–<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nux001</pub-id>
<pub-id pub-id-type="pmid">28444216</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bolduc</surname><given-names>J.-F.</given-names></name><name><surname>Hany</surname><given-names>L.</given-names></name><name><surname>Barat</surname><given-names>C.</given-names></name><name><surname>Ouellet</surname><given-names>M.</given-names></name><name><surname>Tremblaya</surname><given-names>M. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Epigenetic metabolite acetate inhibits class I/II histone deacetylases, promotes histone acetylation, and increases HIV-1 Integration in CD4 T cells</article-title>. <source/>J. Virol.
<volume>91</volume>, <fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01943-16</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Booth</surname><given-names>M. J.</given-names></name><name><surname>Branco</surname><given-names>M. R.</given-names></name><name><surname>Ficz</surname><given-names>G.</given-names></name><name><surname>Oxley</surname><given-names>D.</given-names></name><name><surname>Krueger</surname><given-names>F.</given-names></name><name><surname>Reik</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution</article-title>. <source/>Science (<issue>80</issue>-). <volume>336</volume>, <fpage>934</fpage>–<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1126/science.1220671</pub-id>
<pub-id pub-id-type="pmid">22539555</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Booth</surname><given-names>M. J.</given-names></name><name><surname>Marsico</surname><given-names>G.</given-names></name><name><surname>Bachman</surname><given-names>M.</given-names></name><name><surname>Beraldi</surname><given-names>D.</given-names></name><name><surname>Balasubramanian</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Quantitative sequencing of 5-formylcytosine in DNA at single-base resolution</article-title>. <source/>Nat. Chem.
<volume>6</volume>, <fpage>435</fpage>–<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.1893</pub-id>
<pub-id pub-id-type="pmid">24755596</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bouchard</surname><given-names>L.</given-names></name><name><surname>Rabasa-Lhoret</surname><given-names>R.</given-names></name><name><surname>Faraj</surname><given-names>M.</given-names></name><name><surname>Lavoie</surname><given-names>M.</given-names></name><name><surname>Mill</surname><given-names>J.</given-names></name><name><surname>Pérusse</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction</article-title>. <source/>Am. J. Clin. Nutr.
<volume>91</volume>, <fpage>309</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.2009.28085</pub-id>
<pub-id pub-id-type="pmid">19939982</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boyle</surname><given-names>A. P.</given-names></name><name><surname>Davis</surname><given-names>S.</given-names></name><name><surname>Shulha</surname><given-names>H. P.</given-names></name><name><surname>Meltzer</surname><given-names>P.</given-names></name><name><surname>Margulies</surname><given-names>E. H.</given-names></name><name><surname>Weng</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>High-resolution mapping and characterization of open chromatin across the genome</article-title>. <source/>Cell
<volume>132</volume>, <fpage>311</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.12.014</pub-id>
<pub-id pub-id-type="pmid">18243105</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brindle</surname><given-names>J. T.</given-names></name><name><surname>McKilligin</surname><given-names>E.</given-names></name><name><surname>Tranter</surname><given-names>G.</given-names></name><name><surname>Clarke</surname><given-names>S.</given-names></name><name><surname>Holmes</surname><given-names>E.</given-names></name><name><surname>Nicholson</surname><given-names>J. K.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics</article-title>. <source/>Nat. Med.
<volume>8</volume>, <fpage>1439</fpage>–<lpage>1445</lpage>. <pub-id pub-id-type="doi">10.1038/nm802</pub-id>
<pub-id pub-id-type="pmid">12447357</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buenrostro</surname><given-names>J. D.</given-names></name><name><surname>Giresi</surname><given-names>P. G.</given-names></name><name><surname>Zaba</surname><given-names>L. C.</given-names></name><name><surname>Chang</surname><given-names>H. Y.</given-names></name><name><surname>Greenleaf</surname><given-names>W. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Transposition of native chromatin for multimodal regulatory analysis and personal epigenomics</article-title>. <source/>Nat. Methods
<volume>10</volume>, <fpage>1213</fpage>–<lpage>1218</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2688</pub-id>
<pub-id pub-id-type="pmid">24097267</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bungard</surname><given-names>D.</given-names></name><name><surname>Benjamin</surname><given-names>J.</given-names></name><name><surname>Fuerth</surname></name><name><surname>Zeng</surname><given-names>P.-Y.</given-names></name><name><surname>Faubert</surname><given-names>B.</given-names></name><name><surname>Maas</surname><given-names>N. L.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Signaling kinase AMPK activates stress-promoted transcription <italic>via</italic> histone H2B phosphorylation</article-title>. <source/>Science (80-).
<volume>329</volume>, <fpage>1201</fpage>–<lpage>1205</lpage>. <pub-id pub-id-type="doi">10.1126/science.1191241</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caesar</surname><given-names>R.</given-names></name><name><surname>Tremaroli</surname><given-names>V.</given-names></name><name><surname>Kovatcheva-datchary</surname><given-names>P.</given-names></name><name><surname>Patrice</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling</article-title>. <source/>Cell Metab., <volume>22</volume>, <fpage>658</fpage>–<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.07.026</pub-id>
<pub-id pub-id-type="pmid">26321659</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Sutter</surname><given-names>B. M.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Tu</surname><given-names>B. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes</article-title>. <source/>Mol. Cell
<volume>42</volume>, <fpage>426</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2011.05.004</pub-id>
<pub-id pub-id-type="pmid">21596309</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cani</surname><given-names>P. D.</given-names></name><name><surname>Osto</surname><given-names>M.</given-names></name><name><surname>Geurts</surname><given-names>L.</given-names></name><name><surname>Everard</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity</article-title>. <source/>Gut Microbes
<volume>3</volume>, <fpage>37</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.4161/gmic.19625</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carrier</surname><given-names>T. J.</given-names></name><name><surname>Reitzel</surname><given-names>A. M.</given-names></name></person-group> (<year>2017</year>). <article-title>The hologenome across environments and the implications of a host-associated microbial repertoire</article-title>. <source/>Front. Microbiol.
<volume>8</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.00802</pub-id>
<pub-id pub-id-type="pmid">28197127</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Sprung</surname><given-names>R.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Ball</surname><given-names>H.</given-names></name><name><surname>Sangras</surname><given-names>B.</given-names></name><name><surname>Kim</surname><given-names>S. C.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Lysine propionylation and butyrylation are novel post-translational modifications in histones</article-title>. <source/>Mol. Cell. Proteomics
<volume>6</volume>, <fpage>812</fpage>–<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M700021-MCP200</pub-id>
<pub-id pub-id-type="pmid">17267393</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Christmann</surname><given-names>B. S.</given-names></name><name><surname>Abrahamsson</surname><given-names>T. R.</given-names></name><name><surname>Charles</surname><given-names>N.</given-names></name><name><surname>Duck</surname><given-names>L. W.</given-names></name><name><surname>Mannon</surname><given-names>P. J.</given-names></name><name><surname>Berg</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Human seroreactivity to gut microbiota antigens</article-title>. <source/>J. Allergy Clin. Immunol.
<volume>136</volume>, <fpage>1378</fpage>–<lpage>1386</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2015.03.036</pub-id>
<pub-id pub-id-type="pmid">26014812</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chu</surname><given-names>H.</given-names></name><name><surname>Mazmanian</surname><given-names>S. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Innate immune recognition of the microbiota promotes host-microbial symbiosis</article-title>. <source/>Nat. Immunol.
<volume>14</volume>, <fpage>668</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2635</pub-id>
<pub-id pub-id-type="pmid">23778794</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Churchman</surname><given-names>L. S.</given-names></name><name><surname>Weissman</surname><given-names>J. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Nascent transcript sequencing visualizes transcription at nucleotide resolution</article-title>. <source/>Nature
<volume>469</volume>, <fpage>1</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1038/nature09652</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Core</surname><given-names>L. J.</given-names></name><name><surname>Waterfall</surname><given-names>J. J.</given-names></name><name><surname>Lis</surname><given-names>J. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters</article-title>. <source/>Science (80-).
<volume>322</volume>, <fpage>1845</fpage>–<lpage>1848</lpage>. <pub-id pub-id-type="doi">10.1126/science.1162228</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Filippo</surname><given-names>C.</given-names></name><name><surname>Cavalieri</surname><given-names>D.</given-names></name><name><surname>Di Paola</surname><given-names>M.</given-names></name><name><surname>Ramazzotti</surname><given-names>M.</given-names></name><name><surname>Poullet</surname><given-names>J. B.</given-names></name><name><surname>Massart</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa</article-title>. <source/>Proc. Natl. Acad. Sci. <volume>107</volume>, <fpage>14691</fpage>–<lpage>14696</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1005963107</pub-id>
<pub-id pub-id-type="pmid">20679230</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Down</surname><given-names>T. A.</given-names></name><name><surname>Rakyan</surname><given-names>V. K.</given-names></name><name><surname>Turner</surname><given-names>D. J.</given-names></name><name><surname>Flicek</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Kulesha</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>A bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis</article-title>. <source/>Nat. Biotechnol.
<volume>26</volume>, <fpage>779</fpage>–<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1038/nbt1414</pub-id>
<pub-id pub-id-type="pmid">18612301</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferretti</surname><given-names>P.</given-names></name><name><surname>Pasolli</surname><given-names>E.</given-names></name><name><surname>Tett</surname><given-names>A.</given-names></name><name><surname>Asnicar</surname><given-names>F.</given-names></name><name><surname>Gorfer</surname><given-names>V.</given-names></name><name><surname>Fedi</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Mother-to-infant microbial transmission from different body sites shapes the developing infant gut microbiome</article-title>. <source/>Cell Host Microbe
<volume>24</volume>, <page-range>133–145.e5</page-range>. <pub-id pub-id-type="doi">10.1016/j.chom.2018.06.005</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Franks</surname><given-names>P. W.</given-names></name><name><surname>Ling</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Epigenetics and obesity: the devil is in the details</article-title>. <source/>BMC Med.
<volume>8</volume>, <fpage>88</fpage>. <pub-id pub-id-type="doi">10.1186/1741-7015-8-88</pub-id>
<pub-id pub-id-type="pmid">21176136</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Franzosa</surname><given-names>E. A.</given-names></name><name><surname>Hsu</surname><given-names>T.</given-names></name><name><surname>Sirota-Madi</surname><given-names>A.</given-names></name><name><surname>Shafquat</surname><given-names>A.</given-names></name><name><surname>Abu-Ali</surname><given-names>G.</given-names></name><name><surname>Morgan</surname><given-names>X. C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Sequencing and beyond: integrating molecular “omics” for microbial community profiling</article-title>. <source/>Nat. Rev. Microbiol.
<volume>13</volume>, <fpage>360</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3451</pub-id>
<pub-id pub-id-type="pmid">25915636</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>J. A.</given-names></name><name><surname>Field</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Edwards</surname><given-names>R. A.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Gilna</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Detection of large numbers of novel sequences in the metatranscriptomes of complex marine microbial communities</article-title>. <source/>PLoS One
<volume>3</volume>, <fpage>277</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1002/9781118010549.ch27</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gomes</surname><given-names>A. C.</given-names></name><name><surname>Bueno</surname><given-names>A. A.</given-names></name><name><surname>Souza</surname><given-names>R. G. M.</given-names></name><name><surname>Mota</surname><given-names>J. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Gut microbiota, probiotics and diabetes</article-title>. <source/>J. Clin. Gastroenterol.
<volume>13</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1097/MCG.0000000000001058</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greenblum</surname><given-names>S.</given-names></name><name><surname>Turnbaugh</surname><given-names>P. J.</given-names></name><name><surname>Borenstein</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and in flammatory bowel disease</article-title>. <source/>Proc. Natl. Acad. Sci.
<volume>109</volume>, <fpage>594</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1116053109</pub-id>
<pub-id pub-id-type="pmid">22184244</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Groussin</surname><given-names>M.</given-names></name><name><surname>Mazel</surname><given-names>F.</given-names></name><name><surname>Sanders</surname><given-names>J. G.</given-names></name><name><surname>Smillie</surname><given-names>C. S.</given-names></name><name><surname>Lavergne</surname><given-names>S.</given-names></name><name><surname>Thuiller</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Unraveling the processes shaping mammalian gut microbiomes over evolutionary time</article-title>. <source/>Nat. Commun.
<volume>8</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms14319</pub-id>
<pub-id pub-id-type="pmid">28232747</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Allen-Vercoe</surname><given-names>E.</given-names></name><name><surname>Petrof</surname><given-names>E. O.</given-names></name></person-group> (<year>2016</year>). <article-title>Fecal microbiota transplantation: In perspective</article-title>. <source/>Therap. Adv. Gastroenterol.
<volume>9</volume>, <fpage>229</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1177/1756283X15607414</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hassig</surname><given-names>C. A.</given-names></name><name><surname>Tong</surname><given-names>J. K.</given-names></name><name><surname>Schreiber</surname><given-names>S. L.</given-names></name></person-group> (<year>1997</year>). <article-title>Fiber-derived butyrate and the prevention of colon cancer</article-title>. <source/>Chem. Biol.
<volume>4</volume>, <fpage>783</fpage>–<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(97)90111-3</pub-id>
<pub-id pub-id-type="pmid">9384528</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heintz-Buschart</surname><given-names>A.</given-names></name><name><surname>May</surname><given-names>P.</given-names></name><name><surname>Laczny</surname><given-names>C. C.</given-names></name><name><surname>Lebrun</surname><given-names>L. A.</given-names></name><name><surname>Bellora</surname><given-names>C.</given-names></name><name><surname>Krishna</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes</article-title>. <source/>Nat. Microbiol.
<volume>2</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.180</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hullar</surname><given-names>M. A. J.</given-names></name><name><surname>Fu</surname><given-names>B. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Diet, the gut microbiome, and epigenetics</article-title>. <source/>Cancer J. (United States)
<volume>20</volume>, <fpage>170</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1097/PPO.0000000000000053</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kang</surname><given-names>D. W.</given-names></name><name><surname>Adams</surname><given-names>J. B.</given-names></name><name><surname>Gregory</surname><given-names>A. C.</given-names></name><name><surname>Borody</surname><given-names>T.</given-names></name><name><surname>Chittick</surname><given-names>L.</given-names></name><name><surname>Fasano</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study</article-title>. <source/>Microbiome
<volume>5</volume>, <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1186/s40168-016-0225-7</pub-id>
<pub-id pub-id-type="pmid">28086968</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Katada</surname><given-names>S.</given-names></name><name><surname>Imhof</surname><given-names>A.</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Connecting threads: epigenetics and metabolism</article-title>. <source/>Cell
<volume>148</volume>, <fpage>24</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.01.001</pub-id>
<pub-id pub-id-type="pmid">22265398</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kau</surname><given-names>A. L.</given-names></name><name><surname>Ahern</surname><given-names>P. P.</given-names></name><name><surname>Griffin</surname><given-names>N. W.</given-names></name><name><surname>Goodman</surname><given-names>A. L.</given-names></name><name><surname>Gordon</surname><given-names>J. I.</given-names></name></person-group> (<year>2011</year>). <article-title>Human nutrition, the gut microbiome and the immune system</article-title>. <source/>Nature
<volume>474</volume>, <fpage>327</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1038/nature10213</pub-id>
<pub-id pub-id-type="pmid">21677749</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.-I.</given-names></name></person-group> (<year>2005</year>). <article-title>Nutritional epigenetics: impact of folate deficiency on dna methylation and colon cancer susceptibility</article-title>. <source/>J. Nutr.
<volume>135</volume>, <fpage>2694</fpage>–<lpage>2697</lpage>. <pub-id pub-id-type="doi">10.1093/jn/135.11.2703</pub-id>
<pub-id pub-id-type="pmid">16251632</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kivioja</surname><given-names>T.</given-names></name><name><surname>Vähärautio</surname><given-names>A.</given-names></name><name><surname>Karlsson</surname><given-names>K.</given-names></name><name><surname>Bonke</surname><given-names>M.</given-names></name><name><surname>Enge</surname><given-names>M.</given-names></name><name><surname>Linnarsson</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Counting absolute numbers of molecules using unique molecular identifiers</article-title>. <source/>Nat. Methods
<volume>9</volume>, <fpage>72</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1778</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knight</surname><given-names>R.</given-names></name><name><surname>Navas</surname><given-names>J.</given-names></name><name><surname>Quinn</surname><given-names>R. A.</given-names></name><name><surname>Sanders</surname><given-names>J. G.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name></person-group> (<year>2018</year>). <article-title>Best practices for analysing microbiomes</article-title>. <source/>Nat. Rev. Microbiol.
<volume>16</volume>, <fpage>410</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-018-0029-9</pub-id>
<pub-id pub-id-type="pmid">29795328</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kola</surname><given-names>B.</given-names></name><name><surname>Grossman</surname><given-names>A. B.</given-names></name><name><surname>Korbonits</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>The role of AMP-activated protein kinase in obesity</article-title>. <source/>Front. Horm. Res.
<volume>36</volume>, <fpage>198</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1159/000115366</pub-id>
<pub-id pub-id-type="pmid">18230904</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kootte</surname><given-names>R. S.</given-names></name><name><surname>Levin</surname><given-names>E.</given-names></name><name><surname>Salojärvi</surname><given-names>J.</given-names></name><name><surname>Smits</surname><given-names>L. P.</given-names></name><name><surname>Hartstra</surname><given-names>A. V.</given-names></name><name><surname>Udayappan</surname><given-names>S. D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition</article-title>. <source/>Cell Metab.
<volume>26</volume>, <page-range>611–619.e6</page-range>. <pub-id pub-id-type="doi">10.1016/j.cmet.2017.09.008</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koppel</surname><given-names>N.</given-names></name><name><surname>Rekdal</surname><given-names>V. M.</given-names></name><name><surname>Balskus</surname><given-names>E. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Chemical transformation of xenobiotics by the human gut microbiota</article-title>. <source/>Science (80-).
<volume>356</volume>, <fpage>1246</fpage>–<lpage>1257</lpage>. <pub-id pub-id-type="doi">10.1126/science.aag2770</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krautkramer</surname><given-names>K. A.</given-names></name><name><surname>Kreznar</surname><given-names>J. H.</given-names></name><name><surname>Romano</surname><given-names>K. A.</given-names></name><name><surname>Vivas</surname><given-names>E. I.</given-names></name><name><surname>Barrett-Wilt</surname><given-names>G. A.</given-names></name><name><surname>Rabaglia</surname><given-names>M. E.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues</article-title>. <source/>Mol. Cell
<volume>64</volume>, <fpage>982</fpage>–<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2016.10.025</pub-id>
<pub-id pub-id-type="pmid">27889451</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krautkramer</surname><given-names>K. A.</given-names></name><name><surname>Rey</surname><given-names>F. E.</given-names></name><name><surname>Denu</surname><given-names>J. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Chemical signaling between gut microbiota and host chromatin: What is your gut really saying</article-title>? <source/>J. Biol. Chem. <volume>292</volume>, <fpage>8582</fpage>–<lpage>8593</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R116.761577</pub-id>
<pub-id pub-id-type="pmid">28389558</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lahiri</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>N.</given-names></name><name><surname>Solis-Mezarino</surname><given-names>V.</given-names></name><name><surname>Fedisch</surname><given-names>A.</given-names></name><name><surname>Ninkovic</surname><given-names>J.</given-names></name><name><surname>Feuchtinger</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>In situ detection of histone variants and modifications in mouse brain using imaging mass spectrometry</article-title>. <source/>Proteomics
<volume>16</volume>, <fpage>437</fpage>–<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.201500345</pub-id>
<pub-id pub-id-type="pmid">26593131</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laker</surname><given-names>R. C.</given-names></name><name><surname>Garde</surname><given-names>C.</given-names></name><name><surname>Camera</surname><given-names>D. M.</given-names></name><name><surname>Smiles</surname><given-names>W. J.</given-names></name><name><surname>Zierath</surname><given-names>J. R.</given-names></name><name><surname>Hawley</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Transcriptomic and epigenetic responses to short-term nutrient-exercise stress in humans</article-title>. <source/>Sci. Rep.
<volume>7</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-15420-7</pub-id>
<pub-id pub-id-type="pmid">28127051</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landry</surname><given-names>B. P.</given-names></name><name><surname>Tabor</surname><given-names>J. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Engineering diagnostic and therapeutic gut bacteria</article-title>. <source/>Microbiol. Spectr.
<volume>5</volume>, <fpage>1</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1128/microbiolspec.BAD-0020-2017</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Langdon</surname><given-names>A.</given-names></name><name><surname>Crook</surname><given-names>N.</given-names></name><name><surname>Dantas</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation</article-title>. <source/>Genome Med.
<volume>8</volume>, <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1186/s13073-016-0294-z</pub-id>
<pub-id pub-id-type="pmid">26750923</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lieberman-Aiden</surname><given-names>E.</given-names></name><name><surname>Berkum5, van</surname><given-names>N. L.</given-names></name><name><surname>Williams</surname><given-names>L.</given-names></name><name><surname>Imakaev2</surname><given-names>M.</given-names></name><name><surname>Ragoczy</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Comprehensive mapping of long range interactions reveals folding principles of the human genome</article-title>. <source/>Science (80-).
<volume>326</volume>, <fpage>289</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1126/science.1181369</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ling</surname><given-names>C.</given-names></name><name><surname>Groop</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Epigenetics: a molecular link between environmental factors and type 2 diabetes</article-title>. <source/>Diabetes
<volume>58</volume>, <fpage>2718</fpage>–<lpage>2725</lpage>. <pub-id pub-id-type="doi">10.2337/db09-1003</pub-id>
<pub-id pub-id-type="pmid">19940235</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lister</surname><given-names>R.</given-names></name><name><surname>Pelizzola</surname><given-names>M.</given-names></name><name><surname>Dowen</surname><given-names>R. H.</given-names></name><name><surname>Hawkins</surname><given-names>R. D.</given-names></name><name><surname>Hon</surname><given-names>G.</given-names></name><name><surname>Nery</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Human DNA methylomes at base resolution show widespreadepigenomic differences</article-title>. <source/>Nature
<volume>462</volume>, <fpage>315</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1038/nature08514</pub-id>
<pub-id pub-id-type="pmid">19829295</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Da Cunha</surname><given-names>A. P.</given-names></name><name><surname>Rezende</surname><given-names>R. M.</given-names></name><name><surname>Cialic</surname><given-names>R.</given-names></name><name><surname>Wei</surname><given-names>Z.</given-names></name><name><surname>Bry</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The host shapes the gut microbiota <italic>via</italic> fecal MicroRNA</article-title>. <source/>Cell Host Microbe
<volume>19</volume>, <fpage>32</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2015.12.005</pub-id>
<pub-id pub-id-type="pmid">26764595</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Bennett</surname><given-names>B. D.</given-names></name><name><surname>Rabinowitz</surname><given-names>J. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Analytical strategies for LC-MS-based targeted metabolomics</article-title>. <source/>J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci.
<volume>871</volume>, <fpage>236</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchromb.2008.04.031</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maier</surname><given-names>L.</given-names></name><name><surname>Pruteanu</surname><given-names>M.</given-names></name><name><surname>Kuhn</surname><given-names>M.</given-names></name><name><surname>Zeller</surname><given-names>G.</given-names></name><name><surname>Telzerow</surname><given-names>A.</given-names></name><name><surname>Anderson</surname><given-names>E. E.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Extensive impact of non-antibiotic drugs on human gut bacteria</article-title>. <source/>Nature
<volume>555</volume>, <fpage>623</fpage>–<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1038/nature25979</pub-id>
<pub-id pub-id-type="pmid">29555994</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manrique</surname><given-names>P.</given-names></name><name><surname>Dills</surname><given-names>M.</given-names></name><name><surname>Young</surname><given-names>M. J.</given-names></name></person-group> (<year>2017</year>). <article-title>The human gut phage community and its implications for health and disease</article-title>. <source/>Viruses
<volume>9</volume>, <fpage>9</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.3390/v9060141</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manzo</surname><given-names>V. E.</given-names></name><name><surname>Bhatt</surname><given-names>A. S.</given-names></name></person-group> (<year>2015</year>). <article-title>The human microbiome in hematopoiesis and hematologic disorders</article-title>. <source/>Blood
<volume>126</volume>, <fpage>311</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2015-04-574392</pub-id>
<pub-id pub-id-type="pmid">26012569</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maslowski</surname><given-names>K. M.</given-names></name><name><surname>MacKay</surname><given-names>C. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Diet, gut microbiota and immune responses</article-title>. <source/>Nat. Immunol.
<volume>12</volume>, <fpage>5</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ni0111-5</pub-id>
<pub-id pub-id-type="pmid">21169997</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menni</surname><given-names>C.</given-names></name><name><surname>Jackson</surname><given-names>M. A.</given-names></name><name><surname>Pallister</surname><given-names>T.</given-names></name><name><surname>Steves</surname><given-names>C. J.</given-names></name><name><surname>Spector</surname><given-names>T. D.</given-names></name><name><surname>Valdes</surname><given-names>A. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain</article-title>. <source/>Int. J. Obes. <volume>41</volume>, <fpage>1099</fpage>–<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1038/ijo.2017.66</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>K. D.</given-names></name><name><surname>Saletore</surname><given-names>Y.</given-names></name><name><surname>Zumbo</surname><given-names>P.</given-names></name><name><surname>Elemento</surname><given-names>O.</given-names></name><name><surname>Mason</surname><given-names>C. E.</given-names></name><name><surname>Jaffrey</surname><given-names>S. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Comprehensive Analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons</article-title>. <source/>Cell
<volume>149</volume>, <fpage>1635</fpage>–<lpage>1646</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.05.003</pub-id>
<pub-id pub-id-type="pmid">22608085</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mortazavi</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>B. A.</given-names></name><name><surname>McCue</surname><given-names>K.</given-names></name><name><surname>Schaeffer</surname><given-names>L.</given-names></name><name><surname>Wold</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title>. <source/>Nat. Methods
<volume>5</volume>, <fpage>621</fpage>–<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1226</pub-id>
<pub-id pub-id-type="pmid">18516045</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muegge</surname><given-names>B. D.</given-names></name><name><surname>Kuczynski</surname><given-names>J.</given-names></name><name><surname>Knights</surname><given-names>D.</given-names></name><name><surname>Clemente</surname><given-names>J. C.</given-names></name><name><surname>Fontana</surname><given-names>L.</given-names></name><name><surname>Henrissat</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans</article-title>. <source/>Science (80-). <volume>332</volume>, <fpage>970</fpage>–<lpage>974</lpage>. <pub-id pub-id-type="doi">10.1126/science.1198719</pub-id>
<pub-id pub-id-type="pmid">21596990</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagpal</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Ahmadi</surname><given-names>S.</given-names></name><name><surname>Hayes</surname><given-names>J.</given-names></name><name><surname>Gagliano</surname><given-names>J.</given-names></name><name><surname>Subashchandrabose</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome</article-title>. <source/>Sci. Rep.
<volume>8</volume>, <fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-30114-4</pub-id>
<pub-id pub-id-type="pmid">29311619</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pamer</surname><given-names>E. G.</given-names></name></person-group> (<year>2014</year>). <article-title>Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns</article-title>. <source/>Mucosal Immunol.
<volume>7</volume>, <fpage>210</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2013.117</pub-id>
<pub-id pub-id-type="pmid">24399149</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patti</surname><given-names>G. J.</given-names></name><name><surname>Yanes</surname><given-names>O.</given-names></name><name><surname>Siuzdak</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Metabolomics: the apogee of the omics trilogy</article-title>. <source/>Nat. Cell Biol.
<volume>13</volume>, <fpage>263</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3314</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paul</surname><given-names>B.</given-names></name><name><surname>Barnes</surname><given-names>S.</given-names></name><name><surname>Demark-Wahnefried</surname><given-names>W.</given-names></name><name><surname>Morrow</surname><given-names>C.</given-names></name><name><surname>Salvador</surname><given-names>C.</given-names></name><name><surname>Skibola</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases</article-title>. <source/>Clin. Epigenetics
<volume>7</volume>, <fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1186/s13148-015-0144-7</pub-id>
<pub-id pub-id-type="pmid">25628764</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peleg</surname><given-names>S.</given-names></name><name><surname>Feller</surname><given-names>C.</given-names></name><name><surname>Ladurner</surname><given-names>A. G.</given-names></name><name><surname>Imhof</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>The metabolic impact on histone acetylation and transcription in ageing</article-title>. <source/>Trends Biochem. Sci.
<volume>41</volume>, <fpage>700</fpage>–<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2016.05.008</pub-id>
<pub-id pub-id-type="pmid">27283514</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petrof</surname><given-names>E. O.</given-names></name><name><surname>Khoruts</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>From stool transplants to next-generation microbiota therapeutics</article-title>. <source/>Gastroenterology
<volume>1</volume>, <fpage>233</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.dcn.2011.01.002</pub-id>
</mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poirier</surname><given-names>L. A.</given-names></name><name><surname>Wise</surname><given-names>C. K.</given-names></name><name><surname>Delongchamp</surname><given-names>R. R.</given-names></name><name><surname>Sinha</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>Blood determinations of S -adenosylmethionine, S -adenosylhomocysteine, and homocysteine: correlations with diet</article-title>. <source/>Cancer Epidemiol. Biomarkers Prev.
<volume>10</volume>, <fpage>649</fpage>–<lpage>655</lpage>.<pub-id pub-id-type="pmid">11401915</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Raes</surname><given-names>J.</given-names></name><name><surname>Arumugam</surname><given-names>M.</given-names></name><name><surname>Burgdorf</surname><given-names>S.</given-names></name><name><surname>Manichanh</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>A human gut microbial gene catalog established by metagenomic sequencing</article-title>. <source/>Nature
<volume>464</volume>, <fpage>59</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1038/nature08821</pub-id>
<pub-id pub-id-type="pmid">20203603</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reid</surname><given-names>G.</given-names></name><name><surname>Burton</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Use of Lactobacillus to prevent infection by pathogenic bacteria</article-title>. <source/>Microbes Infect.
<volume>4</volume>, <fpage>319</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/S1286-4579(02)01544-7</pub-id>
<pub-id pub-id-type="pmid">11909742</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ringel</surname><given-names>A. E.</given-names></name><name><surname>Tucker</surname><given-names>S. A.</given-names></name><name><surname>Haigis</surname><given-names>M. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Chemical and physiological features of mitochondrial acylation</article-title>. <source/>Mol. Cell
<volume>72</volume>, <fpage>610</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2018.10.023</pub-id>
<pub-id pub-id-type="pmid">30444998</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Romano</surname><given-names>K. A.</given-names></name><name><surname>Martinez-del Campo</surname><given-names>A.</given-names></name><name><surname>Kasahara</surname><given-names>K.</given-names></name><name><surname>Chittim</surname><given-names>C. L.</given-names></name><name><surname>Vivas</surname><given-names>E. I.</given-names></name><name><surname>Amador-Noguez</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Metabolic, epigenetic, and transgenerational effects of gut bacterial choline consumption</article-title>. <source/>Cell Host Microbe
<volume>22</volume>, <fpage>279</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2017.07.021</pub-id>
<pub-id pub-id-type="pmid">28844887</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sampson</surname><given-names>T.</given-names></name><name><surname>Mazmanian</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Control of brain development, function, and behavior by the microbiome</article-title>. <source/>Cell Host Microbe
<volume>17</volume>, <fpage>565</fpage>–<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2015.04.011</pub-id>
<pub-id pub-id-type="pmid">25974299</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Savage</surname><given-names>D. D. C.</given-names></name></person-group> (<year>1977</year>). <article-title>Microbial ecology of the gastrointestinal tract</article-title>. <source/>Annu. Rev. Microbiol.
<volume>31</volume>, <fpage>107</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.mi.31.100177.000543</pub-id>
<pub-id pub-id-type="pmid">334036</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seeley</surname><given-names>J. J.</given-names></name><name><surname>Baker</surname><given-names>R.</given-names></name><name><surname>Mohamed</surname><given-names>G.</given-names></name><name><surname>Bruns</surname><given-names>T.</given-names></name><name><surname>Hayden</surname><given-names>M. S.</given-names></name><name><surname>Deshmukh</surname><given-names>S. D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Induction of innate immune memory <italic>via</italic> microRNA targeting of chromatin remodeling factors</article-title>. <source/>Nature
<volume>559</volume>, <fpage>114</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0253-5</pub-id>
<pub-id pub-id-type="pmid">29950719</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sender</surname><given-names>R.</given-names></name><name><surname>Fuchs</surname><given-names>S.</given-names></name><name><surname>Milo</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>a). <article-title>Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans</article-title>. <source/>Cell
<volume>164</volume>, <fpage>337</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.01.013</pub-id>
<pub-id pub-id-type="pmid">26824647</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sender</surname><given-names>R.</given-names></name><name><surname>Fuchs</surname><given-names>S.</given-names></name><name><surname>Milo</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>b). <article-title>Revised estimates for the number of human and bacteria cells in the body</article-title>. <source/>PLoS Biol.
<volume>14</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1002533</pub-id>
</mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharon</surname><given-names>G.</given-names></name><name><surname>Garg</surname><given-names>N.</given-names></name><name><surname>Debelius</surname><given-names>J.</given-names></name><name><surname>Knight</surname><given-names>R.</given-names></name><name><surname>Dorrestein</surname><given-names>P. C.</given-names></name><name><surname>Mazmanian</surname><given-names>S. K.</given-names></name></person-group> (<year>2014</year>). <article-title>Specialized metabolites from the microbiome in health and disease</article-title>. <source/>Cell Metab.
<volume>20</volume>, <fpage>719</fpage>–<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.10.016</pub-id>
<pub-id pub-id-type="pmid">25440054</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sidoli</surname><given-names>S.</given-names></name><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Jensen</surname><given-names>O. N.</given-names></name></person-group> (<year>2012</year>). <article-title>Proteomics in chromatin biology and epigenetics: elucidation of post-translational modifications of histone proteins by mass spectrometry</article-title>. <source/>J. Proteomics
<volume>75</volume>, <fpage>3419</fpage>–<lpage>3433</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2011.12.029</pub-id>
<pub-id pub-id-type="pmid">22234360</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Strandwitz</surname><given-names>P.</given-names></name><name><surname>Kim</surname><given-names>K. H.</given-names></name><name><surname>Terekhova</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>J. K.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Levering</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>GABA-modulating bacteria of the human gut microbiota</article-title>. <source/>Nat. Microbiol.
<volume>4</volume>, <fpage>396</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-018-0307-3</pub-id>
<pub-id pub-id-type="pmid">30531975</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thaiss</surname><given-names>C. A.</given-names></name><name><surname>Levy</surname><given-names>M.</given-names></name><name><surname>Korem</surname><given-names>T.</given-names></name><name><surname>Dohnalová</surname><given-names>L.</given-names></name><name><surname>Shapiro</surname><given-names>H.</given-names></name><name><surname>Jaitin</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Microbiota diurnal rhythmicity programs host transcriptome oscillations</article-title>. <source/>Cell
<volume>167</volume>, <page-range>1495–1510.e12</page-range>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.11.003</pub-id>
</mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tillisch</surname><given-names>K.</given-names></name><name><surname>Labus</surname><given-names>J.</given-names></name><name><surname>Kilpatrick</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Stains</surname><given-names>J.</given-names></name><name><surname>Ebrat</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Consumption of Fermented Milk Product with Probiotics Modulates Brain Activity</article-title>. <source/>Gastroenterology
<volume>144</volume>, <fpage>1394</fpage>–<lpage>1401</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2013.02.043</pub-id>
<pub-id pub-id-type="pmid">23474283</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ting</surname><given-names>J. P. Y.</given-names></name><name><surname>Trowsdale</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Genetic control of MHC class II expression</article-title>. <source/>Cell
<volume>109</volume>, <fpage>21</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(02)00696-7</pub-id>
</mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trial</surname><given-names>R. D. P.</given-names></name><name><surname>Reijnders</surname><given-names>D.</given-names></name><name><surname>Goossens</surname><given-names>G. H.</given-names></name><name><surname>Hermes</surname><given-names>G. D. A.</given-names></name><name><surname>Zoetendal</surname><given-names>E. G.</given-names></name><name><surname>Dejong</surname><given-names>C. H. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans</article-title>. <source/>Cell Metab.
<volume>24</volume>, <fpage>63</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.06.016</pub-id>
<pub-id pub-id-type="pmid">27411009</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turnbaugh</surname><given-names>P. J.</given-names></name><name><surname>Bäckhed</surname><given-names>F.</given-names></name><name><surname>Fulton</surname><given-names>L.</given-names></name><name><surname>Gordon</surname><given-names>J. I.</given-names></name></person-group> (<year>2008</year>). <article-title>Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome</article-title>. <source/>Cell Host Microbe
<volume>3</volume>, <fpage>213</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2008.02.015</pub-id>
<pub-id pub-id-type="pmid">18407065</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turnbaugh</surname><given-names>P. J.</given-names></name><name><surname>Hamady</surname><given-names>M.</given-names></name><name><surname>Yatsunenko</surname><given-names>T.</given-names></name><name><surname>Cantarel</surname><given-names>B. L.</given-names></name><name><surname>Duncan</surname><given-names>A.</given-names></name><name><surname>Ley</surname><given-names>R. E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>A core gut microbiome in obese and lean twins</article-title>. <source/>Nature
<volume>457</volume>, <fpage>480</fpage>–<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1038/nature07540</pub-id>
<pub-id pub-id-type="pmid">19043404</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tyson</surname><given-names>G. W.</given-names></name><name><surname>Chapman</surname><given-names>J.</given-names></name><name><surname>Hugenholtz</surname><given-names>P.</given-names></name><name><surname>Allen</surname><given-names>E. E.</given-names></name><name><surname>Ram</surname><given-names>R. J.</given-names></name><name><surname>Richardson</surname><given-names>P. M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Community structure and metabolism through reconstruction of microbial genomes from the environment</article-title>. <source/>Nature
<volume>428</volume>, <fpage>37</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/nature02340</pub-id>
<pub-id pub-id-type="pmid">14961025</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Umesaki</surname><given-names>Y.</given-names></name><name><surname>Okada</surname><given-names>Y.</given-names></name><name><surname>Matsumoto</surname><given-names>S.</given-names></name><name><surname>Imaoka</surname><given-names>A.</given-names></name><name><surname>Setoyama</surname><given-names>H.</given-names></name></person-group> (<year>1995</year>). <article-title>Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC Class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse</article-title>. <source/>Microbiol. Immunol.
<volume>39</volume>, <fpage>555</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1111/j.1348-0421.1995.tb02242.x</pub-id>
<pub-id pub-id-type="pmid">7494493</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ursell</surname><given-names>L. K.</given-names></name><name><surname>Metcalf</surname><given-names>J. L.</given-names></name><name><surname>Parfrey</surname><given-names>L. W.</given-names></name><name><surname>Knight</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Definig the human microbiome</article-title>. <source/>Nutr. Rev.
<volume>70</volume>, <fpage>S38</fpage>–<lpage>S44</lpage>. <pub-id pub-id-type="doi">10.1111/j.1753-4887.2012.00493.x</pub-id>
</mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ussar</surname><given-names>S.</given-names></name><name><surname>Fujisaka</surname><given-names>S.</given-names></name><name><surname>Kahn</surname><given-names>C. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome</article-title>. <source/>Mol. Metab.
<volume>5</volume>, <fpage>795</fpage>–<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmet.2016.07.004</pub-id>
<pub-id pub-id-type="pmid">27617202</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van de Guchte</surname><given-names>M.</given-names></name><name><surname>Blottière</surname><given-names>H. M.</given-names></name><name><surname>Doré</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Humans as holobionts: implications for prevention and therapy</article-title>. <source/>Microbiome
<volume>6</volume>, <fpage>81</fpage>. <pub-id pub-id-type="doi">10.1186/s40168-018-0466-8</pub-id>
<pub-id pub-id-type="pmid">29716650</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Nood</surname><given-names>E.</given-names></name><name><surname>Vrieze</surname><given-names>A.</given-names></name><name><surname>Nieuwdorp</surname><given-names>M.</given-names></name><name><surname>Fuentes</surname><given-names>S.</given-names></name><name><surname>Zoetendal</surname><given-names>E. G.</given-names></name><name><surname>de Vos</surname><given-names>W. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Duodenal infusion of donor feces for recurrent clostridium difficile</article-title>. <source/>N. Engl. J. Med.
<volume>368</volume>, <fpage>407</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1205037</pub-id>
<pub-id pub-id-type="pmid">23323867</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wahlström</surname><given-names>A.</given-names></name><name><surname>Sayin</surname><given-names>S. I.</given-names></name><name><surname>Marschall</surname><given-names>H. U.</given-names></name><name><surname>Bäckhed</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism</article-title>. <source/>Cell Metab.
<volume>24</volume>, <fpage>41</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.05.005</pub-id>
<pub-id pub-id-type="pmid">27320064</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Gilchrist</surname><given-names>C. A.</given-names></name><name><surname>Uddin</surname><given-names>M. J.</given-names></name><name><surname>Burgess</surname><given-names>S. L.</given-names></name><name><surname>Abhyankar</surname><given-names>M. M.</given-names></name><name><surname>Moonah</surname><given-names>S. N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Microbiome-mediated neutrophil recruitment via CXCR2 and protection from amebic colitis</article-title>. <source/>PLoS Pathog.
<volume>13</volume>, <fpage>1</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006513</pub-id>
</mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williamson</surname><given-names>I. A.</given-names></name><name><surname>Arnold</surname><given-names>J. W.</given-names></name><name><surname>Samsa</surname><given-names>L. A.</given-names></name><name><surname>Gaynor</surname><given-names>L.</given-names></name><name><surname>DiSalvo</surname><given-names>M.</given-names></name><name><surname>Cocchiaro</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology</article-title>. <source/>Cmgh
<volume>6</volume>, <fpage>301</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2018.05.004</pub-id>
<pub-id pub-id-type="pmid">30123820</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woese</surname><given-names>C. R.</given-names></name><name><surname>Fox</surname><given-names>G. E.</given-names></name></person-group> (<year>1977</year>). <article-title>Phylogenetic structure of the prokaryotic domain: the primary kingdoms</article-title>. <source/>Proc. Natl. Acad. Sci.
<volume>74</volume>, <fpage>5088</fpage>–<lpage>5090</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.74.11.5088</pub-id>
<pub-id pub-id-type="pmid">270744</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>G. D.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Hoffmann</surname><given-names>C.</given-names></name><name><surname>Bittinger</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Sue</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Linking long-term dietary patterns with gut microbial enterotypes</article-title>. <source/>Science (80-).
<volume>334</volume>, <fpage>105</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1126/science.1208344</pub-id>
</mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xi</surname><given-names>Y.</given-names></name><name><surname>Bock</surname><given-names>C.</given-names></name><name><surname>Müller</surname><given-names>F.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Meissner</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name></person-group> (<year>2012</year>). <article-title>RRBSMAP: a fast, accurate and user-friendly alignment tool for reduced representation bisulfite sequencing</article-title>. <source/>Bioinformatics
<volume>28</volume>, <fpage>430</fpage>–<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btr668</pub-id>
<pub-id pub-id-type="pmid">22155871</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yano</surname><given-names>J. M.</given-names></name><name><surname>Yu</surname><given-names>K.</given-names></name><name><surname>Donaldson</surname><given-names>G. P.</given-names></name><name><surname>Shastri</surname><given-names>G. G.</given-names></name><name><surname>Ann</surname><given-names>P.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis</article-title>. <source/>Cell
<volume>161</volume>, <fpage>264</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.02.047</pub-id>
<pub-id pub-id-type="pmid">25860609</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yatsunenko</surname><given-names>T.</given-names></name><name><surname>Rey</surname><given-names>F. E.</given-names></name><name><surname>Manary</surname><given-names>M. J.</given-names></name><name><surname>Trehan</surname><given-names>I.</given-names></name><name><surname>Dominguez-Bello</surname><given-names>M. G.</given-names></name><name><surname>Contreras</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Human gut microbiome viewed across age and geography</article-title>. <source/>Nature
<volume>486</volume>, <fpage>222</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1038/nature11053</pub-id>
<pub-id pub-id-type="pmid">22699611</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Youle</surname><given-names>M.</given-names></name><name><surname>Knowlton</surname><given-names>N.</given-names></name><name><surname>Rohwer</surname><given-names>F.</given-names></name><name><surname>Gordon</surname><given-names>J.</given-names></name><name><surname>Relman</surname><given-names>D. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Superorganisms and holobionts</article-title>. <source/>Microbe Mag.
<volume>8</volume>, <fpage>152</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1128/microbe.8.152.1</pub-id>
</mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Ding</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Lam</surname><given-names>Y. Y.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes</article-title>. <source/>Sci.
<volume>1156</volume>, <fpage>1151</fpage>–<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1126/science.aao5774</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>